BioMarin Pharmaceutical | BMRN - Market Capitalization

Stock Price
64.08
Daily Change
0.66 1.04%
Monthly
12.88%
Yearly
-6.11%
Q1 Forecast
62.09

BioMarin Pharmaceutical reported $12.09B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 1.6B 16M Feb/2026
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
Amgen USD 201.45B 25.2B Feb/2026
Bayer EUR 27.23B 2.14B Sep/2025
Biogen USD 27.01B 1.19B Feb/2026
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Gilead Sciences USD 183.59B 31.31B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
Insmed USD 23.91B 13.21B Feb/2026
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Moderna USD 16.5B 6.41B Feb/2026
Neurocrine Biosciences USD 13.68B 465M Feb/2026
PTC Therapeutics USD 5.36B 744M Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 118.94B 1.6B Feb/2026
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 1.94B 284M Feb/2026
United Therapeutics USD 18.96B 6B Sep/2025
Vertex Pharmaceuticals USD 120.12B 5.09B Feb/2026